Product Description
Abiraterone acetate 250mg Tablets IP is a medication used in the treatment of prostate cancer. It is often prescribed for patients with metastatic castration-resistant prostate cancer (mCRPC). Abiraterone works by inhibiting an enzyme called CYP17, which is involved in the production of. The standard dosage of Abiraterone acetate is commonly 250 mg once daily, usually taken on an empty stomach or at least two hours after a meal. Moreover, we ensure to provide the genuine Abiraterone acetate 250mg Tablets IP in safe packaging options and at market leading prices.
Packaging Size |
120 Tablets |
Brand |
Xbira |
Composition |
Abiraterone Acetate |
Prescription/Non prescription |
Prescription |
Strength |
250 mg |
Form |
Tablet |
Treatment |
Treat Prostate cancer that has metastasized (spread to other parts of the body). |
Manufactured By |
Cipla |
Medicine Type |
Allopathic |
Packaging Type |
Bottle |
FAQs of Abiraterone Acetate 250mg Tablets IP:
Q: What is the physical form of Abiraterone Acetate 250mg Tablets IP?
A: The physical form of Abiraterone Acetate 250mg Tablets IP is tablets.
Q: What are the storage instructions for Abiraterone Acetate 250mg Tablets IP?
A: The storage instructions for Abiraterone Acetate 250mg Tablets IP are to keep it in a dry place.
Q: What are the dosage guidelines for Abiraterone Acetate 250mg Tablets IP?
A: The dosage guidelines for Abiraterone Acetate 250mg Tablets IP are to take as per instructions.
Q: What is the drug type of Abiraterone Acetate 250mg Tablets IP?
A: The drug type of Abiraterone Acetate 250mg Tablets IP is general medicines.
Q: How should I take Abiraterone Acetate 250mg Tablets IP?
A: You should take Abiraterone Acetate 250mg Tablets IP as suggested by your healthcare provider.